MeiraGTx Holdings MGTX
NASDAQ MGTX
$13.89 -0.08 (-0.57%)
As of: Sep 4, 2026 · 3:59 PM EDT

MeiraGTx Holdings (MGTX) Change in Receivables (2021 - 2023)

MeiraGTx Holdings' (MGTX) quarterly Change in Receivables came in at $3.6 million in Q2 2023, up 206.16% YoY from $1.2 million in Q2 2022, and up 125.36% on a QoQ basis from -$14.1 million in Q1 2023.

Analysis

MeiraGTx Holdings (MGTX) Change in Receivables (2021 - 2023) Analysis & Trends

MeiraGTx Holdings (MGTX) has 3 years of Change in Receivables data on file, last reported at $3.6 million in Q2 2023.

  • Quarterly Change in Receivables rose 206.16% year-over-year to $3.6 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was -$15.3 million (changed N/A YoY) and the FY2022 annual result came in at $1.0 million, down 93.7% from the prior year.
  • Change in Receivables advanced to $3.6 million in Q2 2023, from -$14.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $9.2 million in Q1 2022 to a low of -$14.1 million in Q1 2023.
  • A 3-year average of -$2.1 million and a median of -$3.4 million in 2022 frame the typical range for Change in Receivables.
  • The widest YoY moves for Change in Receivables: up 206.16% in 2023, down 254.15% in 2023.
  • Tracing MGTX's Change in Receivables over 3 years: stood at -$5.1 million in 2021, then soared by 162.48% to $3.2 million in 2022, then climbed by 12.66% to $3.6 million in 2023.
  • The last three Change in Receivables figures came in at $3.6 million (Q2 2023), -$14.1 million (Q1 2023), and $3.2 million (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 140.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 838.50 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -53.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 117.58 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 31.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 37.16 Mn
10 MeiraGTx Holdings 1.27 Bn 1.13 Bn 315.67 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 3.59 Mn
Mar 31, 2023 -14.14 Mn
Dec 31, 2022 3.18 Mn
Sep 30, 2022 -7.94 Mn
Jun 30, 2022 -3.38 Mn
Mar 31, 2022 9.17 Mn
Dec 31, 2021 -5.09 Mn